Quote | Mereo BioPharma Group (NASDAQ:MREO)
Last: | $2.99 |
---|---|
Change Percent: | 0.33% |
Open: | $3.03 |
Close: | $2.99 |
High: | $3.03 |
Low: | $2.875 |
Volume: | 507,424 |
Last Trade Date Time: | 05/22/2024 03:00:00 am |
News | Mereo BioPharma Group (NASDAQ:MREO)
2024-05-15 17:20:06 ET More on Mereo BioPharma Group Mereo BioPharma's Pipeline Promise Vs. Valuation And Market Realities Mereo BioPharma Group GAAP EPS of -$0.04 Seeking Alpha’s Quant Rating on Mereo BioPharma Group Read the full article on Seeking...
2024-05-15 17:04:04 ET More on Mereo BioPharma Group Mereo BioPharma's Pipeline Promise Vs. Valuation And Market Realities Mereo BioPharma Group GAAP EPS of -$0.04 Read the full article on Seeking Alpha For further details see: Mereo BioPharma Group GAAP ...
Message Board Posts | Mereo BioPharma Group (NASDAQ:MREO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $MREO News Article - Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual | whytestocks | investorshangout | 04/13/2023 12:05:47 PM |
znewcar1: $MREO 34% v2,5M C.75 f124,985M H.7734 ML.4945 YL.51 | znewcar1 | investorshangout | 12/30/2022 9:41:53 PM |
whytestocks: $MREO News Article - Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capita | whytestocks | investorshangout | 09/26/2022 2:40:59 PM |
znewcar1: MREO 30% v53M C1.69 f117M H1.85 | znewcar1 | investorshangout | 06/21/2022 9:15:25 PM |
whytestocks: $MREO News Article - Mereo BioPharma to Participate in a Fireside Chat at the 10th Annu | whytestocks | investorshangout | 02/18/2021 1:15:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Mereo BioPharma Group Company Name:
MREO Stock Symbol:
NASDAQ Market:
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and prov...
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutica...
LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate ...